CCK8 results demonstrated that the combination of quinidine and 8-Br-cGMP in vitro more effectively inhibited the growth of prostate cancer cells, and knocking down HSPB6 could reverse this effect (Fig. 8A, B). This evidence concerns the gene HSPB6 and prostate cancer.